Compounds > orphenadrine
Page last updated: 2024-11-01

orphenadrine and Labyrinth Diseases

orphenadrine has been researched along with Labyrinth Diseases in 2 studies

Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.

Labyrinth Diseases: Pathological processes of the inner ear (LABYRINTH) which contains the essential apparatus of hearing (COCHLEA) and balance (SEMICIRCULAR CANALS).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Camarda, V1
Di Carlo, A1
Marchiori, C1
Russolo, M1

Trials

1 trial available for orphenadrine and Labyrinth Diseases

ArticleYear
A controlled study of the effect of orphenadrine hydrochloride (Disipal) on vertigo in patients with spontaneous vestibular disease.
    The British journal of clinical practice, 1982, Volume: 36, Issue:5

    Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Labyrinth Diseases; Orphenadrine; Vertigo; Ve

1982

Other Studies

1 other study available for orphenadrine and Labyrinth Diseases

ArticleYear
[Data on the use of orphenadrine in the medical treatment of vertiginpus syndromes].
    Minerva medica, 1969, Feb-14, Volume: 60, Issue:13

    Topics: Humans; Labyrinth Diseases; Neurilemmoma; Neuritis; Orphenadrine; Vertigo; Vestibulocochlear Nerve

1969